High-Risk Localized And Locally Advanced Prostate Cancer

Around 20%-30% of nonmetastatic prostate cancer patients have high-risk localized disease. The best treatment for high-risk localized disease is still unclear, and the reliability of the definition of "high-risk" may need to be validated first. Although recent advances in radiotherapy for prostate cancer have yielded excellent long-term results, even in high-risk localized disease, there are no studies directly comparing it with local treatment options, such as prostatectomy. To address current challenges in high-risk localized and locally advanced prostate cancer, 12 original and 3 review articles covering aspects from basic research to clinical trials are published in this Special Issue.

• | Author: Kouji Izumi
• | Publisher: Mdpi Ag
• | Publication Date: Jul 14, 2023
• | Number of Pages: 244 pages
• | Language: English
• | Binding: Hardcover
• | ISBN-10: 3036581685
• | ISBN-13: 9783036581682